We use cookies.

To make your experience the best it can be, we use cookies and similar technologies on our site. We need your permission to allow these technologies, which will maximise browsing experience.
For more information on how we use cookies and how to change your cookie settings, please see our cookies and privacy policy. Accept Deny.

Request a callback

BePlas Product update: Biomaster Antimicrobial Technology now shown to destroy 99% of SARS-CoV-2 after 24 hours.

BePlas Elite Sterling has been used extensively in the Nightingale Hospitals around the UK for its hygienic properties. It has been specified widely in the fight to reduce the spread the of the SARS-CoV-2 virus. It is designed to help make places safer for both staff and patients.

And it can help protect even more lives in many other building types including care homes, schools, hotels, manufacturing, food production, student accommodation hospitality and residential schemes.

SARS-CoV-2 is the virus that causes Covid-19 and is a member of the Coronavirus family of viruses.

Commenting on Beplas being involved in the supply of antimicrobial products, Managing Director Jay Moorhouse stated “We are incredibly proud to be playing our part in supporting hygiene. The latest news from Addmaster is fantastic and is now proof that it is an effective product used in many applications, including our own products. On a personal level, helping create hygienic environments in this difficult time has been one of the most important things I have done in my life”.

Beplas are currently testing their product independently to incorporate results into their NBS specifications: https://source.thenbs.com/manufacturer/be-plas-hygienic-walls-ceilings-ltd/c9J2zzJiqjWvWFdYLXXdwC/overview

Biomaster confirmed this week that after extensive testing they can reveal that Biomaster is active on both porous and non-porous substrates against SARS-CoV-2.

Download our updated specifiers guide here

"We are very excited to be sharing these game-changing results with our Biomaster partners, as they have been extremely patient in waiting for the availability of SARS-CoV-2 testing," comments Addmaster Founder & CEO Paul Morris.

"Having the data to prove the technology is effective against SARS-CoV-2 on both substrate types is a huge step change for the industry and it will now allow the technology to be rolled out quickly across all markets."

Read more about the results from Biomaster here


To view BePlas Elite Sterling containing Biomaster click here

If you have any questions, our team are on hand. Call us directly on 0800 413 758